Discussing The Future Of CRISPR-Cas: Gene Editing Takes Center Stage At CRISPRcon

Wednesday, August 16, 2017 - Thursday, August 17, 2017

Discussing The Future Of CRISPR-Cas: Gene Editing Takes Center Stage At CRISPRcon

Location: University of California, Berkeley
Description: The conference is the first of its kind to bring together farmers, doctors, patients, environmentalists, consumers, nonprofits, community leaders, and more to discuss the CRISPR-Cas technology. CRISPRcon will provide a unique forum to explore a wide range of potential applications, from human and animal health to agriculture and conservation.

"Fulfilling the promise and the potential of CRISPR technology requires collaboration and thoughtful, open dialogue," says Jennifer Doudna, professor at the University of California, Berkeley, and a pioneer in the field of CRISPR biology and genome editing. "CRISPRcon will provide a forum for the kind of honest discourse we need to examine what a future with CRISPR technology might look like, and what its continued advancement might require in terms of policy and oversight."

CRISPR technology allows for precise changes to be made to the DNA of living cells, which holds the potential to eradicate diseases, transform agriculture, and enable massive leaps forward in environmental and life science. Through a series of keynotes, panels, and interactive discussions, CRISPRcon will provide a forum for everyone with a stake in CRISPR to share ideas, ask and answer questions, and explore the path forward.

The Keystone Policy Center is facilitating this one-and-a-half-day event, and has crafted a program to examine the social dimensions of CRISPR in medicine, food, and the environment, as well as the role of regulation and social acceptance in determining the future of CRISPR. Dr. Doudna will provide opening remarks; Greg Simon, the director of the Biden Cancer Initiative, will deliver a keynote address; and KQED's Host of Forum, Michael Krasny, will act as emcee.
Contact Information: